Tumor diagnostic kits
DETECTION/ QUANTIFICATION OF MINIMAL RESIDUAL DISEASE (MRD) IN HEMATOLOGY/ONCOLOGY |
|
LIPSGENE® M-BCR/t(9;22) Kit: |
The LIPSGENE® M-BCR/t(9;22) Kit is intended for real-time PCR in vitro quantification of preformed BCR-ABL fusion transcript cDNA comprising the (Ph+) translocation t(9;22) major breakpoint cluster regions (M-BCR) b2a2 and b3a2, in total RNA or mRNA samples prepared from crude or purified human white blood cells obtained from blood or bone marrow aspirates. (more information: LIPSGENE® M-BCR/ t(9;22) Kit) |
LIPSGENE® mi-BCR/t(9;22) Kit: |
The LIPSGENE® mi-BCR/t(9;22) Kit is intended for real-time PCR in vitro quantification of preformed BCR-ABL fusion transcript cDNA comprising the (Ph+) translocation t(9;22) minor breakpoint cluster region (M-BCR) e1a2, in total RNA or mRNA samples prepared from crude or purified human white blood cells obtained from blood or bone marrow aspirates. (more information: LIPSGENE® mi-BCR/ t(9;22) Kit) |
LIPSGENE® TEL-AML1/t(12;21) Kit: |
The LIPSGENE® TEL-AML1/t(12;21) Kit is intended for real-time quantification of TEL-AML1 fusion transcripts t(12;21), the most frequent rearrangement in childhood ALL, in total RNA or mRNA samples prepared from crude or purified human white blood cells obtained from blood or bone marrow aspirates. (more information: LIPSGENE® TEL-AML1/ t(12;21) Kit) |
LIPSGENE® PML-RARA/t(15;17) Kit: |
The LIPSGENE® PML-RARA/t(15;17) Kit is intended for real-time quantification of PML-RARA fusion transcripts in AML with M3 cytomorphology [t(15;17)] covering the breakpoint region of PML locus intron 6 (bcr1), in total RNA or mRNA samples prepared from crude or purified human white blood cells obtained from blood or bone marrow aspirates. (more information: LIPSGENE® PML-RARA_t(15;17) Kit) |
LIPSGENE® HER2/NEU Kit: |
The LIPSGENE® HER2/NEU Kit is intended for real-time quantification of HER2/NEU transcripts. (more information: LIPSGENE® HER2/NEU Kit) |
LIPSGENE® Tyrosinase Kit: |
The LIPSGENE® Tyrosinase Kit is intended for real-time quantification of tyrosinase transcripts. (more information: LIPSGENE® Tyrosinase Kit) |
LIPSGENE® Survivin Kit: | The LIPSGENE® Survivin cDNA Quantification Kit is intended for in vitro quantification of total survivin transcripts (Inhibitor of Apoptosis [IAP] family), including all known splice variants, in total RNA/mRNA samples. (more information: LIPSGENE® Survivin Kit) |
REFERENCE GENE TRANSCRIPTS/ “HOUSEKEEPING GENES” |
|
LIPSGENE® c-ABL Kit: |
The LIPSGENE® c-ABL Kit is intended for real-time PCR in vitro quantification of preformed c-ABL transcript cDNA, in total RNA or mRNA samples prepared from crude or purified human white blood cells from blood or bone marrow aspirates. (more information: LIPSGENE® c-ABL Kit) |
LIPSGENE® GAPDH Kit: |
The LIPSGENE® GAPDH Kit is intended for real-time PCR in vitro quantification of preformed glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcript cDNA, in total RNA or mRNA samples prepared from crude or purified cells of human, mice, rat, hamster, guinea pig and bovine origin. (more information: LIPSGENE® GAPDH Kit) |
LIPSGENE® 18S rRNA Kit: |
The LIPSGENE® 18S rRNA Kit is intended for real-time PCR in vitro quantification of preformed 18S ribosomal transcript cDNA, in total RNA or mRNA samples prepared from crude or purified cells of human, mice, rat and rabbit origin. (more information: LIPSGENE® 18S rRNA Kit) |